Steris
STERIS plc (NYSE: STE) provides products and services that support patient care, with an emphasis on infection prevention, serving healthcare providers, medical device manufacturers, and pharmaceutical companies worldwide. Its offerings include consumables, capital equipment, equipment installation and maintenance,… From the company’s description.
In fiscal 2026, Steris reported revenue of $5.94B, up 8.7% from fiscal 2025, and net income of $785.10M. Its operating margin was 18.6%, and operations generated $1.34B in cash. Over the twelve months to Jun 30, 2026, revenue was $6.04B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Steris does
In the company’s own words
STERIS plc (NYSE: STE) provides products and services that support patient care, with an emphasis on infection prevention, serving healthcare providers, medical device manufacturers, and pharmaceutical companies worldwide. Its offerings include consumables, capital equipment, equipment installation and maintenance, instrument and endoscope repair, laboratory testing, outsourced reprocessing, and connectivity solutions. STERIS reports three segments: Healthcare, which supplies infection-prevention products, procedural equipment, and related services to hospitals and other care settings; Applied Sterilization Technologies, which provides contract sterilization, laboratory testing, and sterilization equipment and controls to medical device and pharmaceutical manufacturers; and Life Sciences, which supplies products and services for biopharmaceutical and medical device manufacturing, particularly aseptic production. The company averaged approximately 18,000 employees worldwide in fiscal 2026. Its product portfolio includes V-PRO sterilizers and VAPROX HC sterilant. Its website is http://www.steris-ir.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- DUBLIN, L2
- Fiscal year end
- March
- CIK
- 1757898
- SIC
- 3842
Financial performance, year by year
Fiscal 2016–2026 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Steris — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Steris’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Steris and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Steris's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Steris's last four quarterly filings that the numbers alone won't show?”